Home / Business and Economy / West Pharma CEO Plans Retirement After 11 Years
West Pharma CEO Plans Retirement After 11 Years
10 Mar
Summary
- CEO Eric Green will retire in the second half of 2026.
- West Pharmaceutical develops components for injectable drugs.
- Company sales doubled and shareholder return was 350% under Green.
Eric Green, CEO of West Pharmaceutical, has announced his intention to retire from the company. This planned retirement is scheduled to occur in the second half of 2026, following an 11-year leadership tenure.
An executive search firm has been engaged to find Mr. Green's successor. During his time as CEO since 2015, West Pharmaceutical experienced significant growth, with sales more than doubling and delivering a total shareholder return of approximately 350%.
West Pharmaceutical specializes in manufacturing components and devices essential for injectable drugs, including treatments for diabetes and obesity. The company anticipates continued growth in demand for GLP-1 therapies, albeit at a moderated pace compared to the previous year.
The company also reaffirmed its annual financial forecast, which was initially issued in February. This indicates a stable outlook despite the upcoming leadership change.
